Cargando…

Association of C-myc and p53 Gene Expression and Polymorphisms with Hepatitis C (HCV) Chronic Infection, Cirrhosis and Hepatocellular Carcinoma (HCC) Stages in Egypt

The aim of this study is to investigate c-myc and p53 gene expression and polymorphisms in different stages of HCV infection,. Expression levels of c-myc and p53 were evaluated by RT-PCR and polymorphisms were determined by PCR-RFLP in 60 HCV patients classified into chronic infection, cirrhosis and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koutb, Fayed, Abdel-Rahman, Salah, Hassona, Ehab, Haggag, Amany
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697458/ https://www.ncbi.nlm.nih.gov/pubmed/28843220 http://dx.doi.org/10.22034/APJCP.2017.18.8.2049

Ejemplares similares

Factors Associated with Appropriate Hepatocellular Carcinoma (HCC) Screening Among Chronic Hepatitis C (HCV) Patients with Cirrhosis at an Urban Safety-net Hospital System
por: Cabrera, Nicolo, et al.
Publicado: (2017)

p53, Bcl-2 and C-Myc Expressions in Colorectal Carcinoma Associated with Schistosomiasis in Egypt
por: Zalata, Khaled R., et al.
Publicado: (2005)

Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC)
por: Zhao, Pin, et al.
Publicado: (2021)

Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC
por: De Battista, Davide, et al.
Publicado: (2021)

Problems of Long Survival Following Surgery in Patients with NonBNonC-HCC: Comparison with HBV and HCV Related-HCC
por: Hiwatashi, Kiyokazu, et al.
Publicado: (2015)

Is expert opinion reliable when estimating transition probabilities? The case of HCV-related cirrhosis in Egypt
por: Cousien, Anthony, et al.
Publicado: (2014)

HCC: RNA-Sequencing in Cirrhosis
por: Wang, Haoyu, et al.
Publicado: (2023)

The Impact of Hepatitis C Virus (HCV) Treatment with Direct-Acting (DAA) on the Incidence of Hepatocellular Carcinoma (HCC) in Patients with Advanced Liver Disease
por: De Comarmond, Charles, et al.
Publicado: (2017)

Genetic Polymorphisms of Fas/FasL Promoter Associated with Hepatitis C cirrhosis and HCC
por: Abed, Sally, et al.
Publicado: (2017)

SLC35B4 Stabilizes c-MYC Protein by O-GlcNAcylation in HCC
por: Jiang, Tao, et al.
Publicado: (2022)

TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients
por: Körner, Christian, et al.
Publicado: (2012)

Evaluation of Osteopontin as a Biomarker in Hepatocellular Carcinomas in Egyptian Patients with Chronic HCV Cirrhosis
por: Abdel-Hafiz, Samah Mamdouh, et al.
Publicado: (2018)

Efficacy and Safety of Microwave Ablation (MWA) for Hepatocellular Carcinoma (HCC) in Difficult Anatomical Sites in Egyptian Patients with Liver Cirrhosis
por: Soliman, Ahmad F, et al.
Publicado: (2019)

Surgical Strategies for Combined Hepatocellular-Cholangiocarcinoma (cHCC-CC)
por: Bahra, Marcus, et al.
Publicado: (2023)

Impact of deranged B cell subsets distribution in the development of HCV-related cirrhosis and HCC in type two diabetes mellitus
por: Abdelwahab, Fadwa A., et al.
Publicado: (2020)

Carcinovic cohort: prognostic factors of death in HIV/HCV coinfected patients with hepatocellular carcinoma (HCC)
por: Gelu-Simeon, M, et al.
Publicado: (2014)

Androgen receptor variant 7 exacerbates hepatocarcinogenesis in a c-MYC-driven mouse HCC model
por: Kido, Tatsuo, et al.
Publicado: (2023)

Aggressive primary gastric lymphoma (PGL) masquerading as hepatocellular cancer (HCC) in alcoholic cirrhosis
por: Ahmed, Moiz, et al.
Publicado: (2021)

Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC)
por: Dhanasekaran, Renumathy, et al.
Publicado: (2017)

Factors associated with hepatocellular carcinoma occurrence after HCV eradication in patients without cirrhosis or with compensated cirrhosis
por: Abe, Kazumichi, et al.
Publicado: (2020)

Depression in Public Servants of Upper Egypt: Gender-specific Prevalence and Determining Factors
por: Eshak, Ehab Salah, et al.
Publicado: (2022)

The Interactions Between HBV and the Innate Immunity of Hepatocytes
por: Megahed, Fayed Attia Koutb, et al.
Publicado: (2020)

Methylene tetrahydrofolate reductase (MTHFR) and vascular endothelial growth factor (VEGF) polymorphisms in Brazilian patients with Hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC)
por: Carvalho, Sylene C.R., et al.
Publicado: (2021)

Detection of MicroRNA in Hepatic Cirrhosis and Hepatocellular Carcinoma in Hepatitis C Genotype-4 in Egyptian Patients
por: Demerdash, Hala M., et al.
Publicado: (2017)

Accurate prediction of HCC risk after SVR in patients with hepatitis C cirrhosis based on longitudinal data
por: Zou, Yanzheng, et al.
Publicado: (2023)

Genetic polymorphisms related to the vitamin D pathway in patients with cirrhosis with or without hepatocellular carcinoma (HCC)
por: de Jesus Brait, Beatriz, et al.
Publicado: (2022)

Plasma Protein Biomarkers of Hepatocellular Carcinoma in HCV-Infected Alcoholic Patients with Cirrhosis
por: Ferrín, Gustavo, et al.
Publicado: (2015)

Role of Pirh2 in Mediating the Regulation of p53 and c-Myc
por: Hakem, Anne, et al.
Publicado: (2011)

Differentially Expressed Proteins in Chronic Active Hepatitis, Cirrhosis, and HCC Related to HCV Infection in Comparison With HBV Infection: A proteomics study
por: Sarvari, Jamal, et al.
Publicado: (2013)

TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis
por: Nomair, Azhar Mohamed, et al.
Publicado: (2021)

Challenge of hepatitis C in Egypt and hepatitis B in Mauritania
por: Raad, Issam I, et al.
Publicado: (2018)

The Putative Role of Natural Killer Cells in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma
por: Hassona, Mona M, et al.
Publicado: (2021)

A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy
por: Guo, Feifei, et al.
Publicado: (2021)

Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients
por: Li, Xu, et al.
Publicado: (2019)

Beneficial therapeutic effects of Nigella sativa and/or Zingiber officinale in HCV patients in Egypt
por: Abdel-Moneim, Adel, et al.
Publicado: (2013)

Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011)

HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta‐analysis
por: Lockart, Ian, et al.
Publicado: (2022)

Interleukin-6 polymorphisms in HCC patients chronically infected with HCV
por: Adnan, Faisal, et al.
Publicado: (2020)

CD8(+) T Cell Responses during HCV Infection and HCC
por: Hofmann, Maike, et al.
Publicado: (2021)

Expression of hnRNPK & Claudin-4 in HCV-Induced Early HCC and Adjacent Liver Tissue
por: Hammam, Olfat, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q4ukc41th3g82i5b6a8l9tjo5a